Status:
RECRUITING
Chinese Second Hip Fracture Evaluation
Lead Sponsor:
Beijing Jishuitan Hospital
Conditions:
Hip Fractures
Osteoporosis
Eligibility:
All Genders
50-95 years
Brief Summary
1. To Compare overall rates of second hip fractures in both genders, 2. To determine the effect of hip fracture on proximal femoral volumetric bone mineral density (vBMD), bone structure and muscle by...
Detailed Description
Osteoporotic hip fracture is a great harm among elderly people, for whom disability and death often occurs. Furthermore, sustaining an osteoporotic hip fracture increases the risk of a subsequent frac...
Eligibility Criteria
Inclusion
- a:Osteoporotic patients b:Osteoporotic hip fracture patients (femoral neck fracture and femoral trochanteric fracture) c: Be willing to and be able to join in the study and sighed the informed consent
Exclusion
- a:Under 47years old b:Non-surgical repair of hip fracture c:Pathologic fracture d:Violence-related trauma e:Bilateral hip implants or have hip replacement on the non-fractured side
Key Trial Info
Start Date :
May 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2026
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT03461237
Start Date
May 1 2017
End Date
November 1 2026
Last Update
August 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing ji shui tan hospital
Beijing, Beijing Municipality, China, 100035